| 臺大學術典藏 |
2022-08-23T02:35:04Z |
Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC)
|
Lu L.-S.; Wu Y.-W.; Chang J.T.-C.; Chang W.-T.; Chao T.-H.; Chen H.H.-W.; Chen Y.-J.; Cheng K.-H.; Hsu W.-L.; Hung C.-L.; SUNG-HSIN KUO; Liang J.-A.; Lin H.-J.; Liu P.-Y.; Liu W.-S.; Liu Y.-W.; Shueng P.-W.; Wang C.-Y.; Hou C.J.-Y.; Chiou J.-F.; TASTRO-TSOC Cardio-Oncology Task Force |
| 臺大學術典藏 |
2022-08-23T02:35:04Z |
Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)
|
Yang W.-C.; Chen Y.-F.; Yang C.-C.; Wu P.-F.; Chan H.-M.; Chen J.L.-Y.; Chen G.-Y.; Cheng J.C.-H.; SUNG-HSIN KUO; Hsu F.-M. |
| 臺大學術典藏 |
2022-08-23T02:35:03Z |
Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy
|
Chen Y.-L.; Tsai C.-L.; Cheng J.C.-H.; Wang C.-W.; Yang S.-H.; Tien Y.-W.; SUNG-HSIN KUO |
| 臺大學術典藏 |
2022-08-23T02:35:03Z |
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders
|
Dai M.-S.; Liu L.-C.; Wang M.-Y.; Lo C.; Chang S.; Tan K.T.; Chen S.-J.; SUNG-HSIN KUO; Huang C.-S.; Yeh D.-C.; Tseng L.-M.; Lee Y.-H.; Chen S.-T.; Lin P.-H. |
| 臺大學術典藏 |
2022-08-23T02:35:03Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-08-23T02:35:02Z |
miR-155-regulated mTOR and Toll-like receptor 5 in gastric diffuse large B-cell lymphoma
|
Huang W.-T.; SUNG-HSIN KUO; Kuo Y.-C.; Lin C.-W. |
| 臺大學術典藏 |
2022-08-23T02:35:01Z |
Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
|
SUNG-HSIN KUO; Yeh K.-H.; Lin C.-W.; Liou J.-M.; Wu M.-S.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-23T02:35:00Z |
Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma
|
Bai L.-Y.; Hsu C.; Yang S.-H.; Lee J.-C.; Chen B.-B.; SUNG-HSIN KUO |
| 臺大學術典藏 |
2022-06-14T23:24:22Z |
Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma
|
Yang, Shih Hung; JEN-CHIEH LEE; BANG-BIN CHEN; SUNG-HSIN KUO; CHIUN HSU; Bai, Li Yuan |
| 臺大學術典藏 |
2022-05-17T07:54:35Z |
Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC)
|
Lu, Long Sheng; YEN-WEN WU; Chang, Joseph Tung Chieh; Chang, Wei Ting; Chao, Ting Hsing; Chen, Helen Hai Wen; YU-JEN CHEN; Cheng, Kai Hung; Hsu, Wen Lin; Hung, Chung Lieh; SUNG-HSIN KUO; Liang, Ji An; HUNG-JU LIN; Liu, Ping Yen; Liu, Wen Shan; Liu, Yen Wen; Shueng, Pei Wei; Wang, Chao Yung; Hou, Charles Jia Yin; Chiou, Jeng Fong |
| 臺大學術典藏 |
2022-03-14T23:45:41Z |
Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC)
|
Lu, Long Sheng; YEN-WEN WU; Chang, Joseph Tung Chieh; Chang, Wei Ting; Chao, Ting Hsing; Chen, Helen Hai Wen; YU-JEN CHEN; Cheng, Kai Hung; Hsu, Wen Lin; Hung, Chung Lieh; SUNG-HSIN KUO; Liang, Ji An; HUNG-JU LIN; Liu, Ping Yen; Liu, Wen Shan; Liu, Yen Wen; Shueng, Pei Wei; Wang, Chao Yung; Hou, Charles Jia Yin; Chiou, Jeng Fong |
| 臺大學術典藏 |
2022-03-14T23:44:59Z |
Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
|
SUNG-HSIN KUO; KUN-HUEI YEH; CHUNG-WU LIN; JYH-MING LIOU; MING-SHIANG WU; Chen, Li Tzong; ANN-LII CHENG |
| 臺大學術典藏 |
2022-02-14T23:55:15Z |
Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy
|
Chen, Yi Lun; CHIAO-LING TSAI; Chia-Hsien Cheng; Chun-wei Wang; Shih-Hung Yang; Yu-Wen Tien; Sung-Hsin Kuo |
| 臺大學術典藏 |
2022-02-07T07:49:00Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-02-07T07:49:00Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
Yang S.-H.; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; SUNG-HSIN KUO; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-02-07T07:48:59Z |
miR-155-regulated mTOR and Toll-like receptor 5 in gastric diffuse large B-cell lymphoma
|
Huang W.-T.; SUNG-HSIN KUO; Kuo Y.-C.; Lin C.-W. |
| 臺大學術典藏 |
2022-02-07T07:48:59Z |
Evaluation of antitumor immunity by a combination treatment of high-dose irradiation, anti-PDL1, and anti-angiogenic therapy in murine lung tumors
|
Chen J.L.-Y.; Pan C.-K.; Huang Y.-S.; Tsai C.-Y.; Wang C.-W.; Lin Y.-L.; SUNG-HSIN KUO; Shieh M.-J. |
| 臺大學術典藏 |
2022-02-07T07:48:58Z |
Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial
|
Yang W.-C.; Chen Y.-F.; Yang C.-C.; Wu P.-F.; Chan H.-M.; Chen J.L.-Y.; Chen G.-Y.; Cheng J.C.-H.; SUNG-HSIN KUO; Hsu F.-M. |
| 臺大學術典藏 |
2022-02-07T07:48:58Z |
Real?world evaluation of modern adjuvant radiotherapy in women with stage ib endometrial cancer
|
Chen J.L.-Y.; Huang C.-Y.; Huang Y.-S.; Hsu C.-Y.; Lan K.-H.; Shih I.-L.; Cheng W.-F.; Chen C.-A.; Sheu B.-C.; SUNG-HSIN KUO |
| 臺大學術典藏 |
2022-02-07T07:48:57Z |
First Asian population study of stereotactic body radiation therapy for ventricular arrhythmias
|
Ho L.-T.; Chen J.L.-Y.; Chan H.-M.; Huang Y.-C.; Su M.-Y.; SUNG-HSIN KUO; Chang Y.-C.; Lin J.-L.; Chen W.-J.; Lee W.-J.; Lin L.-Y. |
| 臺大學術典藏 |
2022-02-07T07:48:57Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
Lin P.-H.; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; SUNG-HSIN KUO; Huang C.-S. |
| 臺大學術典藏 |
2022-02-07T07:48:56Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling
|
SUNG-HSIN KUO; Yang S.-H.; Wei M.-F.; Lee H.-W.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-02-07T07:48:55Z |
Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer
|
Chen J.L.-Y.; Pan C.-K.; Lin Y.-L.; Tsai C.-Y.; Huang Y.-S.; Yang W.-C.; Hsu F.-M.; SUNG-HSIN KUO; Shieh M.-J. |
| 臺大學術典藏 |
2022-01-22T00:04:55Z |
Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)
|
Yang, Wen Chi; YA-FANG CHEN; Yang, Chi Cheng; Wu, Pei Fang; Chan, Hsing Min; JENNY LING-YU CHEN; Chen, Guann Yiing; CHIA-HSIEN CHENG; SUNG-HSIN KUO; FENG-MING HSU |
| 臺大學術典藏 |
2022-01-15T00:07:37Z |
miR-155-regulated mTOR and Toll-like receptor 5 in gastric diffuse large B-cell lymphoma
|
Huang, Wei Ting; SUNG-HSIN KUO; Kuo, Yi Chun; CHUNG-WU LIN |
